Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (841-850 of 1,066) with videos related to

Pageof 107
Sort By:
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420Sherif S Farag, Stephen L George, Edward J Lee, et al.
Blood|September 20, 2002
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restorationPierluigi Porcu, Charles F Eisenbeis, Ronald P Pelletier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agentsRosa Lapalombella, Xiaobin Zhao, Georgia Triantafillou, et al.
Blood|May 9, 2001
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 lociL J Rush, Z Dai, D J Smiraglia, et al.
Plos One|April 2, 2019
Prevalence estimation of Italian ovine cystic echinococcosis in slaughterhouses: A retrospective Bayesian data analysis, 2010-2015Federica Loi, Paola Berchialla, Gabriella Masu, et al.
Cancer Research|March 5, 2003
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphomaSameek Roychowdhury, Ruoqi Peng, Robert A Baiocchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemiaS M Tanner, J L Austin, G Leone, et al.
Blood|January 10, 2008
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitroAruna Gowda, Julie Roda, Syed-Rehan A Hussain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Michael A Caligiuri, et al.
Pageof 107

Showing results (841-850 of 1,066) with videos related to

Sort By:
Pageof 107
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420Sherif S Farag, Stephen L George, Edward J Lee, et al.
Blood|September 20, 2002
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restorationPierluigi Porcu, Charles F Eisenbeis, Ronald P Pelletier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agentsRosa Lapalombella, Xiaobin Zhao, Georgia Triantafillou, et al.
Blood|May 9, 2001
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 lociL J Rush, Z Dai, D J Smiraglia, et al.
Plos One|April 2, 2019
Prevalence estimation of Italian ovine cystic echinococcosis in slaughterhouses: A retrospective Bayesian data analysis, 2010-2015Federica Loi, Paola Berchialla, Gabriella Masu, et al.
Cancer Research|March 5, 2003
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphomaSameek Roychowdhury, Ruoqi Peng, Robert A Baiocchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemiaS M Tanner, J L Austin, G Leone, et al.
Blood|January 10, 2008
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitroAruna Gowda, Julie Roda, Syed-Rehan A Hussain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720Maria R Baer, Stephen L George, Michael A Caligiuri, et al.
Pageof 107